Cormorant Asset Management’s Sangamo Therapeutics SGMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-194,274	Closed	-$2.23M	–	69
2018 Q4	$2.23M	Sell	194,274 -5,726	-3%	-$65.7K	0.18%	60
2018 Q3	$3.39M	Sell	200,000 -182,192	-48%	-$3.09M	0.22%	50
2018 Q2	$5.43M	Hold	382,192	–	–	0.4%	46
2018 Q1	$7.26M	Sell	382,192 -17,808	-4%	-$338K	0.54%	31
2017 Q4	$6.56M	Hold	400,000	–	–	0.69%	30
2017 Q3	$6M	Hold	400,000	–	–	1.06%	28
2017 Q2	$3.52M	Sell	400,000 -200,000	-33%	-$1.76M	0.58%	45
2017 Q1	$3.12M	Sell	600,000 -50,000	-8%	-$260K	0.45%	49
2016 Q4	$1.98M	Sell	650,000 -752,331	-54%	-$2.3M	0.27%	61
2016 Q3	$6.49M	Hold	1,402,331	–	–	0.72%	43
2016 Q2	$8.12M	Buy	+1,402,331	New	+$8.12M	1.15%	31
2015 Q4	–	Sell	-361,000	Closed	-$2.04M	–	89
2015 Q3	$2.04M	Hold	361,000	–	–	0.33%	60
2015 Q2	$4M	Sell	361,000 -81,000	-18%	-$898K	0.53%	45
2015 Q1	$6.93M	Sell	442,000 -58,000	-12%	-$909K	1.07%	29
2014 Q4	$7.61M	Hold	500,000	–	–	1.17%	25
2014 Q3	$5.39M	Hold	500,000	–	–	1.11%	27
2014 Q2	$7.64M	Sell	500,000 -100,000	-17%	-$1.53M	2.02%	16
2014 Q1	$10.8M	Buy	600,000 +433,800	+261%	+$7.84M	2.49%	16
2013 Q4	$2.31M	Buy	+166,200	New	+$2.31M	0.67%	25